Website profiles · Technology insights · Alternatives

synviscone.com

Synvisc-One (hylan G-F 20) can provide you up to six months of osteoarthritis (OA) knee pain relief with a single injection.

No paid content found
Visit website
Profile views 9 Outbound visits 14 Normal
Synvisc-One® Official Site Full homepage screenshot

At a glance

Category
Health & Medical
Language
English
Paid-content signal
No paid content foundObserved
Registered
2007
Hosting
Amazon CloudFrontInferred
HTTPS certificate trusted
PassedObserved
Last updated

Website review

This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.

What is Synvisc-One?

Synvisc-One is a single-injection treatment for knee osteoarthritis (OA) pain. Its active ingredient is hylan G-F 20, a form of hyaluronic acid used as a viscosupplement: it is injected into the knee joint to supplement the synovial fluid that cushions and lubricates the joint. According to the official site, one injection may provide up to six months of pain relief.

Who it is for

  • Adults with knee OA whose pain has not responded adequately to non-drug measures such as exercise and weight management, or to simple pain relievers.
  • People seeking a lower-frequency option than treatments requiring repeated visits.

Practical points

  • It is given by a healthcare professional, typically in a clinic setting.
  • It is not a cure for osteoarthritis and does not reverse cartilage damage.
  • Because it is a single dose, the convenience trade-off is that relief depends on one injection rather than a series.
  • Suitability depends on individual medical history; a clinician assesses whether it is appropriate.

More details, including safety information, are available at Synvisc-One® Official Site.

How does Synvisc-One work to relieve knee pain?

Synvisc-One is a single-injection treatment for osteoarthritis (OA) knee pain. Its active substance, hylan G-F 20, is a gel-like form of hyaluronic acid, a substance naturally present in joint fluid. In an OA knee, that fluid becomes thinner, so the joint has less cushioning and lubrication. The injection is intended to supplement the joint fluid, which may help restore some of that cushioning and support smoother movement, reducing pain signals associated with bone-on-bone friction.

What to expect

  • A healthcare provider administers it as one injection into the knee.
  • The official site describes relief lasting up to six months for some patients.
  • It is used for knee OA, not for other joints or for non-OA knee pain.
  • Response varies; some people get little or no benefit.

Who it may suit

It is typically considered for people with knee OA who have not found enough relief from non-drug measures such as exercise and weight management, or from simple pain relievers, and who prefer an interval treatment over daily medication. It is not a cure, and it does not reverse cartilage damage.

Trade-offs

A single injection is convenient compared with multi-injection courses, but it is an in-office procedure with possible side effects such as temporary knee pain, swelling or stiffness. Because individual results differ, discussing candidacy, alternatives and expectations with a clinician is essential. More detail is available at Synvisc-One® Official Site.

How long does Synvisc-One provide pain relief?

According to the official site, Synvisc-One (hylan G-F 20) is described as providing up to six months of osteoarthritis knee pain relief from a single injection. That is the headline duration the manufacturer promotes, and it is the figure most relevant to people comparing it with other knee OA options.

A few practical points follow from that claim:

  • Single-injection format. The appeal is convenience: one injection rather than a series of visits, which may suit people who want less frequent clinic time.
  • "Up to" is a ceiling, not a guarantee. Individual results vary; some people may get relief for a shorter period, and the site does not promise a fixed duration for everyone.
  • Relief is for knee OA symptoms. It is a viscosupplementation treatment, not a cure for osteoarthritis, and it is intended for knee pain rather than other joints.

For context, the same manufacturer also offers a multi-injection version of the product, typically given as a course of injections. The trade-off is more visits versus a different dosing schedule.

Because duration, suitability and side effects depend on your knee and history, the official page is best used to understand the treatment and prepare questions for a clinician. The manufacturer's site is Synvisc-One® Official Site.

Is Synvisc-One FDA-approved and what are its side effects?

Synvisc-One is a single-injection treatment for osteoarthritis knee pain, and the official site presents it as an option that may provide up to six months of relief. It is a prescription product, so eligibility and appropriateness are determined by a clinician rather than by the website.

H3 Regulatory status The product is described on its official site as an FDA-approved treatment. Approval applies to the specific indication and formulation; it does not mean the treatment is right for every person with knee pain, and it is not a cure for osteoarthritis.

H3 Side effects As with any injection into the knee, side effects can occur. Commonly discussed reactions include:

  • Pain, swelling, warmth or stiffness at the injection site
  • Redness or fluid accumulation around the knee
  • Headache or back pain

Less common but more serious reactions may include severe joint swelling or inflammation, infection, or allergic reactions. Some people experience a reaction after a repeat injection. Because risks vary with medical history and other treatments, the official site and the prescribing information are the appropriate places to review warnings, and a clinician can explain how they apply.

For full details, see Synvisc-One Official Site.

Who is a good candidate for Synvisc-One injections?

A good candidate for Synvisc-One is typically an adult with osteoarthritis (OA) of the knee who has not found enough relief from non-drug measures such as exercise, weight management or physical therapy, or from simple pain relievers. Because the product is given as a single injection intended to relieve knee pain for up to about six months, it may particularly suit people who want a long-lasting option without frequent dosing or daily medication.

It may also be considered by people who cannot take, or do not respond well to, other oral pain medicines, and by those who wish to delay or avoid knee replacement surgery. A clinician usually confirms the diagnosis, checks that the knee joint is suitable for injection, and reviews the person's medical history.

Synvisc-One is not for everyone. It is generally not recommended for people with active knee joint infection, some skin infections near the injection site, or known allergy to its components. Candidacy is a medical judgement, so anyone considering it should discuss symptoms, previous treatments and risks with a qualified healthcare professional. More background is available at Synvisc-One® Official Site.

How is Synvisc-One administered and is it covered by insurance?

How Synvisc-One is administered

Synvisc-One is a single-injection treatment for knee osteoarthritis, given by a healthcare professional. The injection is placed directly into the knee joint, so administration happens in a clinic or office setting rather than at home. Because it is a one-dose product, patients do not need a series of repeat visits for the injection itself, though follow-up care depends on the clinician’s judgment.

The official site presents it as an option for people seeking knee pain relief over an extended period, with the source describing up to six months of relief from a single injection. It is typically positioned for patients whose symptoms are not adequately managed by other approaches, and a doctor decides whether it is appropriate based on the joint and medical history.

Insurance coverage

The site does not state specific coverage details in the supplied information. In practice, insurance coverage for viscosupplementation varies by plan, insurer and country, and may require prior authorization or documentation of earlier treatments. Patients in the United States often check with their insurer or the clinic’s billing staff, while those elsewhere may find it handled differently or not covered at all.

For the manufacturer’s own framing, see Synvisc-One® Official Site.

Related questions

More questions →
What Is the Synvisc-One Official Site?

Synviscone.com is the official U.S. brand website for Synvisc-One (hylan G-F 20), a single-injection treatment for osteoarthritis (OA) knee pain. It is a Sanofi US website aimed at U.S. residents, and it splits its content between patients and healthcare professionals. If you are looking for the manufacturer's own explanation of what the treatment is, who it is indicated for, and what to expect around an injection, this is the source to use — but it is a brand site, so it presents the product's case rather than a neutral comparison of options.

What the site covers

The site is organized around the patient journey, from understanding the condition to preparing for and recovering from treatment:

  • About knee osteoarthritis — background on OA of the knee and general treatment options
  • What is Synvisc-One — how the product works, pain relief and side effects, patient stories, and FAQs
  • Treatment with Synvisc-One — preparing for a doctor visit, what happens after an injection, and making the most of treatment
  • Knee exercise center — exercise videos, plus nutrition and weight loss and alternative therapies
  • Doctor Q&A — questions answered by a physician
  • Insurance coverage — a tool to check whether insurance covers Synvisc-One
  • Printable assessment — a form to bring to an appointment to simplify the discussion with your doctor

There is also a short overview video (the page notes it as "available shortly") and a separate section for U.S. healthcare professionals.

The indication, in the site's own terms

The site states that SYNVISC (hylan G-F 20) and SYNVISC-ONE (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

That indication matters for reading the rest of the site: the product is positioned as an option after simpler measures have not worked well enough, not as a first-line treatment.

Safety information the site leads with

Before trying Synvisc-One or SYNVISC, the site says to tell your doctor if you have had an allergic reaction — such as swelling of the face, tongue or throat, respiratory difficulty, rash, itching or hives — to SYNVISC, Synvisc-One, or any hyaluronan-based products. Full details are in the Important Safety Information and Prescribing Information linked from the site.

Who each part of the site is for

Audience What they get
U.S. patients and caregivers Condition background, product explanation, side effects, patient stories, FAQs, exercise and nutrition content, insurance coverage check, printable doctor-visit assessment
U.S. healthcare professionals A separate HCP section, reached through a confirmation prompt noting the site is intended for U.S. healthcare professionals only

The site also shows standard outbound-link notices when you leave the Sanofi US site, stating that Sanofi US does not review the content, accuracy, or completeness of external sites.

Practical notes before you use it

  • U.S. residents only. The site states this directly, and the HCP section repeats the restriction for professionals.
  • It is a brand site. Expect product-focused framing. For a balanced view of how injection therapy compares with other OA knee options, pair it with non-brand sources and your clinician.
  • No pricing is published on the page. The site offers an insurance coverage check rather than cost figures, so do not assume anything about what you would pay.
  • Use the printable assessment. It is designed to structure the conversation at your next appointment, which is the practical next step if you are considering the treatment.
What Safety Information Should I Know Before Getting Synvisc-One?

Before considering Synvisc-One, the most important safety step is telling your doctor if you have ever had an allergic reaction to SYNVISC, Synvisc-One, or any hyaluronan-based product. According to the official site, warning signs of such a reaction include swelling of the face, tongue, or throat; respiratory difficulty; rash; itching; or hives. This information applies to U.S. residents, and it does not replace advice from your healthcare professional.

The Allergic-Reaction Warning Signs to Watch For

The Synvisc-One official site lists specific signs that may indicate an allergic reaction. You should be aware of these before treatment and know what to report:

  • Swelling of the face, tongue, or throat
  • Respiratory difficulty
  • Rash
  • Itching
  • Hives

These are the reactions the site specifically names in its Important Safety Information. If you have experienced any of these after a prior injection or exposure to a hyaluronan-based product, that history is exactly what your doctor needs to know.

What to Tell Your Doctor Before Treatment

The site's guidance centers on one key disclosure: prior allergic reactions. Before trying Synvisc-One or SYNVISC, tell your doctor if you have had an allergic reaction — such as the signs listed above — to SYNVISC, Synvisc-One, or any hyaluronan-based products.

This matters because your medical history shapes whether an injectable treatment is appropriate for you. The site does not provide a full checklist of every condition to disclose, so the practical approach is to share your complete allergy and treatment history with your doctor rather than relying on the website alone.

Where to Find the Full Safety Details

The official site points readers to two documents for complete information:

Resource What it covers
Important Safety Information The safety warnings summarized on the site
Prescribing Information The full prescribing details for healthcare professionals

Both are available on synviscone.com. The site also separates content for patients and healthcare professionals, so make sure you are reading the patient-facing materials if you are researching for yourself.

What Synvisc-One Is Indicated For

Understanding the safety information also means understanding who the treatment is intended for. According to the site, SYNVISC (hylan G-F 20) and SYNVISC-ONE (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, such as acetaminophen.

In other words, it is not positioned as a first-line option. If you have not yet tried conservative approaches and simple pain relievers, that context is part of the conversation with your doctor.

Important Limits of This Information

The site states it is for U.S. residents only. It provides general safety information and links to the Prescribing Information, but it is not a substitute for professional medical advice. Your doctor can assess your individual history, including any prior reactions, and determine whether Synvisc-One is appropriate for you.

If you want to review the details yourself before an appointment, the Important Safety Information and Prescribing Information on the official site are the starting points — then bring your questions to your healthcare professional.

What Other Knee Osteoarthritis Resources Does the Synvisc-One Site Offer?

Beyond information about the injection itself, the Synvisc-One official site (synviscone.com) includes a set of educational resources for people managing knee osteoarthritis (OA). These cover exercise, nutrition and weight loss, alternative therapies, doctor Q&A, and patient stories. They are general education, not a substitute for advice from your own doctor, and the site is intended for U.S. residents.

Knee Exercise Center

The site's Knee Exercise Center is built around knee exercise videos. This is the most hands-on section if you want something to actually do rather than read.

Exercise is one of the conservative, non-pharmacologic approaches that guidelines generally place before or alongside other OA treatments. If you use the videos, treat them as a starting point and confirm with your doctor or physical therapist which movements are appropriate for your knee.

Nutrition and Weight Loss

The site also carries nutrition and weight loss content. Weight management is commonly discussed as part of knee OA care because load on the knee joint is affected by body weight. The site presents this as educational material rather than a prescribed program, so any specific diet or weight-loss target should come from your own clinician.

Alternative Therapies

A separate section covers alternative therapies. This is useful if you have heard about approaches outside standard treatment and want a plain-language overview before raising them with your doctor. The site does not endorse these as replacements for medical care.

Doctor Q&A

The Doctor Q&A section answers common questions in a question-and-answer format. It is a reasonable place to look if you want to understand how a clinician might frame a topic before your appointment.

Patient Stories

Patient Stories offer first-person perspectives from people who have used Synvisc-One. These are individual experiences, so they show what treatment can look like in practice but do not predict your own result.

Treatment and Insurance Tools

Two practical tools sit alongside the educational content:

Resource What it does
Insurance coverage check Lets you find out whether your insurance covers Synvisc-One
Printable doctor assessment A form to bring to your next appointment to simplify the discussion

The site also offers a 2-minute overview video of Synvisc-One, though the page notes it is "available shortly."

What Synvisc-One Is, for Context

SYNVISC and SYNVISC-ONE (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, such as acetaminophen. In other words, the injection is positioned after simpler measures have not worked well enough — which is why the exercise, nutrition, and alternative-therapy content sits alongside it.

Safety Information to Know Before Using the Site's Resources

Before trying Synvisc-One or SYNVISC, tell your doctor if you have had an allergic reaction — such as swelling of the face, tongue, or throat, respiratory difficulty, rash, itching, or hives — to SYNVISC, Synvisc-One, or any hyaluronan-based products. The site's full Important Safety Information and Prescribing Information are the authoritative sources; the educational sections above do not replace them.

How to Use These Resources

  1. Start with the Knee Exercise Center if you want something actionable, and clear the specific exercises with your doctor.
  2. Read Nutrition & Weight Loss and Alternative Therapies to prepare questions, not to self-prescribe.
  3. Check Doctor Q&A and Patient Stories to understand what to expect and what others have experienced.
  4. Use the insurance coverage check and the printable assessment to make your next appointment more productive.

These pages are educational. Decisions about whether Synvisc-One or any other treatment is right for you belong with your healthcare provider.

Where to Find Insurance Coverage and Treatment Preparation Help on the Synvisc-One Site

The Synvisc-One official site (synviscone.com) organizes patient-oriented help into four main areas: an Insurance Coverage section for checking whether your plan covers the treatment, a printable assessment to bring to your doctor, a Treatment With Synvisc-One section covering preparation and after-injection care, and supporting resources such as FAQs and Patient Stories. All of these sit in the site's patient navigation, alongside the safety and prescribing information.

Checking Whether Insurance Covers Synvisc-One

The site's navigation includes an Insurance Coverage entry under the patient menu. The homepage also carries a prompt asking "Does your insurance cover Synvisc-One" with a "FIND OUT" action, which routes you toward that coverage information.

What the site does not state in the available material: which insurers are accepted, what the out-of-pocket cost is, or whether any payment or financing platform is used. No pricing figures or payment links appear in the page evidence, so treat coverage as something to verify through the site's coverage tool and then confirm with your own insurer rather than assuming a specific cost.

Preparing for Your Doctor Visit

Two resources are aimed at the appointment itself:

  • Prepare For Your Doctor Visit — a section under "Treatment With Synvisc-One" that walks through getting ready for the conversation.
  • Printable assessment — the site invites you to "Simplify the discussion with your doctor" by bringing a printable assessment to your next appointment. Printing it in advance gives you a structured way to raise your knee osteoarthritis history and prior treatments.

This matters because Synvisc-One is indicated for knee osteoarthritis pain in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. A doctor visit is therefore the point where that treatment history gets reviewed, not a step you can skip by reading the site alone.

After an Injection and Making the Most of Treatment

The same "Treatment With Synvisc-One" menu continues past the appointment:

  • After A Synvisc-One Injection — guidance for the period following the injection.
  • Make The Most Of Your Treatment — supporting material for the treatment window.

The site describes Synvisc-One (hylan G-F 20) as able to provide up to six months of osteoarthritis knee pain relief with a single injection, which is the context for why the after-injection and "make the most of it" pages exist.

Additional Patient Resources

Beyond coverage and preparation, the patient navigation includes:

Section What it offers
Synvisc-One FAQs / SYNVISC FAQs Answers to common questions about the treatment
Patient Stories First-person accounts from patients
Knee Exercise Center Knee exercise videos, plus nutrition & weight loss and alternative therapies
Doctor Q&A Doctor-answered questions
2-minute video A quick overview of Synvisc-One

Safety Information You Should Read First

Before pursuing coverage or scheduling anything, the site's Important Safety Information applies. Tell your doctor if you have had an allergic reaction — such as swelling of the face, tongue or throat, respiratory difficulty, rash, itching or hives — to SYNVISC, Synvisc-One, or any hyaluronan-based products. The full Prescribing Information is linked from the site, and there is a separate section for U.S. healthcare professionals.

Note also that the site is stated as for U.S. residents only, and some links lead off the Sanofi site to external or unbranded pages that Sanofi does not review for content, accuracy, or completeness.

Practical Order of Operations

  1. Read the Important Safety Information and Prescribing Information.
  2. Use the Insurance Coverage section (or the homepage "FIND OUT" prompt) to check coverage, then confirm details with your insurer.
  3. Print the assessment and bring it to your doctor visit.
  4. After an injection, follow the "After A Synvisc-One Injection" and "Make The Most Of Your Treatment" guidance.
  5. Use the FAQs, Patient Stories, and Knee Exercise Center for ongoing support.
What Is Synvisc-One and How Is It Used for Knee Osteoarthritis?

Synvisc-One (hylan G-F 20) is a single-injection treatment for knee osteoarthritis (OA) pain, given directly into the knee joint. According to the official site, it can provide up to six months of pain relief from one injection. It is indicated for patients who have not responded adequately to conservative non-drug therapy and simple analgesics such as acetaminophen — so it is positioned as a step after basic measures, not a first-line option.

What Synvisc-One Is

Synvisc-One is a hyaluronan-based product. Hyaluronan is a substance found naturally in joint fluid, and Synvisc-One is formulated as an injection into the knee. The official site describes it as a treatment that can relieve OA knee pain with a single injection, with a stated duration of up to six months.

The site also covers SYNVISC, a related hylan G-F 20 product, in a separate FAQ section. If you are comparing the two, the key practical difference the site emphasizes is the injection schedule — Synvisc-One is a single injection, while SYNVISC is a multi-injection regimen.

Who It Is Indicated For

The stated indication is specific:

  • Condition: Pain from osteoarthritis of the knee
  • Prior treatment: Patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen)

That means the typical candidate has already tried things like activity modification, exercise, weight management, or over-the-counter pain relief and still has significant knee pain. Synvisc-One is not described as a replacement for those measures.

How It Is Used

Synvisc-One is administered as an injection into the knee by a healthcare professional. The official site organizes the treatment journey into three stages:

  1. Prepare for your doctor visit — the site offers a printable assessment to help structure the conversation with your doctor.
  2. After a Synvisc-One injection — guidance on what to expect following the procedure.
  3. Make the most of your treatment — supporting content on exercise, nutrition, and weight loss.

The site also includes a Knee Exercise Center with exercise videos and sections on nutrition, weight loss, and alternative therapies, which suggests these are presented as complements to treatment rather than substitutes.

Safety Information You Should Know

The site's Important Safety Information states that before trying Synvisc-One or SYNVISC, you should tell your doctor if you have had an allergic reaction to SYNVISC, Synvisc-One, or any hyaluronan-based products. Examples of such reactions listed include:

  • Swelling of the face, tongue, or throat
  • Respiratory difficulty
  • Rash, itching, or hives

This is a summary of the site's safety notice, not a complete list. The full Prescribing Information is available on the site and is the appropriate source for a complete risk profile.

Practical Notes

  • Insurance coverage: The site includes an insurance coverage section and a tool to check whether your insurance covers Synvisc-One. Coverage is a common practical question, and the site treats it as a distinct step.
  • Audience: The site is intended for U.S. residents. There is a separate section for U.S. healthcare professionals.
  • Patient stories and FAQs: The site hosts patient stories and a Synvisc-One FAQ section, which may help answer questions about the treatment experience.

Where to Go on the Site

If you want to go deeper, the official site's navigation points to these sections:

  • What is Synvisc-One? — product overview
  • Treatment With Synvisc-One — preparation, post-injection, and getting the most from treatment
  • Pain Relief & Side Effects — what to expect
  • Insurance Coverage — coverage check
  • Patient Stories and Synvisc-One FAQs — patient-facing context

For medical decisions, the site's Prescribing Information and your doctor's assessment are the sources that matter. The site itself is a starting point for understanding the option, not a substitute for a clinical evaluation.

Website Overview

An established domain and managed infrastructure suggest continuity of operations and may support dependable delivery, although neither guarantees service quality. Several search or sharing settings need attention. Together they may make snippets, preview images or preferred URLs less consistent across platforms.

Domain and Registration

Registered in 2007, this domain has about 19 years of history. That suggests continuity, although ownership and purpose may have changed. The registrar, CSC Corporate Domains, Inc., specializes in corporate domain and brand management, suggesting attention to domain asset protection. Transfer-protection status is present, helping reduce the risk of unauthorized domain transfers. The domain uses the common .com extension, which is not an independent safety signal.

DNS and Email

The observed email authentication setup is incomplete: SPF is missing. The lowest TTL is 60 seconds, supporting rapid record changes at the cost of more frequent lookups. Nameservers are provided by sanofi-synthelabo.com, indicating managed DNS hosting. DNS and provider evidence indicate traffic passes through the Amazon CloudFront CDN, which may support caching and traffic distribution. The CNAME points to d1g42o6k741tns.cloudfront.net, associated with Amazon CloudFront.

TLS and Certificates

The certificate uses an RSA 2048-bit public key, offering broad client compatibility. The server supplied a complete certificate chain. No organization name is present in the certificate; the available fields are consistent with domain validation. The certificate was issued within the Amazon cloud or CDN ecosystem. The certificate is valid for about 197 days in total, with 113 days remaining.

HTTP and Browser Security

The response lacks these common security headers: CSP, Referrer-Policy, Permissions-Policy. The response requests HTTP Basic authentication. HTTPS is important to protect the credentials in transit. No X-Powered-By header was found, reducing one common source of backend fingerprinting information. The x-cache, via response header indicates a CDN or caching proxy in the delivery path. No obvious internal addresses or debug information were found in the headers.

Technology Stack Analysis

The public page identifies Google Tag Manager, Amazon CloudFront without precise versions, leaving fewer clues for version-specific scanning.

Search and Social Sharing

The title has 70 characters and may be truncated in search results. Open Graph is partially configured; og:image is missing. A meta description is present, with 124 characters. The observed directives allow indexing and link following. No Generator meta tag is publicly exposed.

Hosting and Email

DNSsanofi-synthelabo.com
HostingAmazon CloudFront
EmailNo incoming email service
Approximate IP geolocation (inferred; a CDN or proxy may differ from the origin server) United States flagUnited States Inferred 18.67.76.108

Registration details

RDAP / WHOIS

RegistrarCSC Corporate Domains, Inc.
Registered2007-04-03
Expires2028-04-03
Domain statusclient transfer prohibited
Nameserversns1.sanofi-synthelabo.com、ns2.sanofi-synthelabo.com、ns3.sanofi-synthelabo.com、ns4.sanofi-synthelabo.com
DNSSECunsigned

DNS records

DNS

TypeNameValueTTLPriority
Ad1g42o6k741tns.cloudfront.net18.67.76.10860—
Ad1g42o6k741tns.cloudfront.net18.67.76.4060—
Ad1g42o6k741tns.cloudfront.net18.67.76.5760—
Ad1g42o6k741tns.cloudfront.net18.67.76.9360—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:1a00:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:2000:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:3200:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:8600:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:c000:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:d200:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:d600:5:d943:1a00:93a160—
AAAAd1g42o6k741tns.cloudfront.net2600:9000:2305:f200:5:d943:1a00:93a160—
MXsynviscone.com.9000
NSsynviscone.comns1.sanofi-synthelabo.com900—
NSsynviscone.comns2.sanofi-synthelabo.com900—
NSsynviscone.comns3.sanofi-synthelabo.com900—
NSsynviscone.comns4.sanofi-synthelabo.com900—
TXTsynviscone.comfacebook-domain-verification=8css941sswwtjzq6g8225wot6dremm900—
CNAMEwww.synviscone.comd1g42o6k741tns.cloudfront.net900—
DMARC_dmarc.synviscone.comv=DMARC1; p=quarantine; rua=mailto:[email protected]; ruf=mailto:[email protected]; fo=1;900—

TLS and certificates

TLS / SSL

AssessmentNormal configuration
Supported protocolsTLSv1.2、TLSv1.3
Negotiated protocolTLSv1.3
Certificate subject*.synviscone.com
IssuerAmazon
Valid until2027-01-13T23:59 · Remaining when checked: 113 days
Verification detailsCertificate trust: Passed · Hostname match: Passed

HTTP response headers

HTTP

HeaderValue
content-typetext/html; charset=UTF-8
cache-controlno-cache
serverAmazonS3
strict-transport-securitymax-age=31536000; includeSubDomains
x-frame-optionsDENY
x-content-type-optionsnosniff

Identified technologies

Google Tag ManagerAmazon CloudFront

Pages, Search and Sharing

Meta descriptionSynvisc-One (hylan G-F 20) can provide you up to six months of osteoarthritis (OA) knee pain relief with a single injection.
Canonical URLhttps://www.synviscone.com/
LanguageEnglish (default)
Twitter CardNot detected
All bots 0 allowed · 2 disallowed
  • Disallow/sitecore
  • Disallow/Sitecore

Recent Updates

  • Website images

User reviews (0)

  • No reviews yet.